Julie Weed, Forbes; US Patent Office Issuing Cannabis Patents To A Growing Market
"Can cannabis plants being [sic] patented?
Yes, this is presently a small area of activity, but may also represent opportunity. Plants can be patented in two ways, by way of “utility patents” (like 95% of all patents) or by way of a separate “plant patent” category. Utility patents are much stronger; plant patents are narrowly focused on a single “parent” plant and its direct descendants. By my count, there are currently only 5 US plant patent cases (4 pending applications, 1 issued patent), and 11 utility plant-directed patent cases (8 pending applications, 3 issued patents). Two companies are currently the main players in plants: the plant-focused Biotechnology Institute (Los Angeles CA) has 3 issued patents as well as 2 pending applications, and GW Pharmaceuticals (UK) has two plant-focused applications. GW is notable for having the largest cannabis-directed portfolio (80+ US cases) of all companies in the space, and is particularly focused on methods of treating diseases."
Showing posts with label cannabis patents. Show all posts
Showing posts with label cannabis patents. Show all posts
Monday, July 24, 2017
Wednesday, March 8, 2017
The US government grants cannabis patents even though weed is illegal; Quartz, March 8, 2017
Ephrat Livni, Quartz;
"If you look closely, the US government doesn’t seem as intent on thwarting marijuana development as the rhetoric espoused by some politicians would have you believe. In fact, cannabis seems to be slowly but surely gaining legitimacy, even in federal government circles, despite its Drug Enforcement Administration classification as a schedule 1 substance with no medical use.
The US government grants cannabis patents even though weed is illegal
"If you look closely, the US government doesn’t seem as intent on thwarting marijuana development as the rhetoric espoused by some politicians would have you believe. In fact, cannabis seems to be slowly but surely gaining legitimacy, even in federal government circles, despite its Drug Enforcement Administration classification as a schedule 1 substance with no medical use.
Acceptance is signaled in small but significant ways. For example, the Patent and Trademark Office grants intellectual property rights to companies developing both marijuana plant strains and synthetic weed for industry...
[...S]ome industry insiders, like patent lawyer Erich Veitenheimer, who represented the holders of No. 9095554, believe this is just the beginning, and told Vice that intellectual property wars over marijuana are inevitable. Certainly, players appear to be preparing for these future cannabis battles, lining up ownership rights despite current federal law, as if widespread legalization is a pretty sure thing."
Subscribe to:
Posts (Atom)